
Cameron Joseph
Political Reporter and Editor at Freelance
Washington Bureau Senior Reporter at The Christian Science Monitor
Senior Washington reporter @csmonitor. Almanac of American Politics senior author. Previous work in @guardian @latimes @cjr etc. @vicenews @nydailynews alum.
Articles
-
2 weeks ago |
csmonitor.com | Cameron Joseph
It’s been five years since George Floyd’s murder by a police officer in Minneapolis set off a wave of international protest and the Black Lives Matter movement. And the lawyer who represented Mr. Floyd’s family in the case thinks it’s harder now than then to get his clients justice. Ben Crump has dedicated much of his career to representing the families of Black people who were killed in wrongful death lawsuits.
-
3 weeks ago |
csmonitor.com | Cameron Joseph
President Donald Trump has spent the first four months since his return to the White House pushing as fast, and as far, as he can to achieve his policy goals through an expansive use of executive power. Now, he’s going to need Congress’ help. The president’s “big, beautiful bill,” – a catchall behemoth that aims to incorporate nearly every legislative priority for the Trump administration, including tax cuts and immigration enforcement – is nearing a vote in the House.
-
3 weeks ago |
spherixglobalinsights.com | Cameron Joseph
High rates of biologic naivety, limited switching, and ongoing unmet needs across the gMG landscape create opportunity for brand differentiation. EXTON, Pa, May 15, 2025 — The treatment landscape for generalized myasthenia gravis (gMG) has entered a new era of therapeutic innovation. Since 2022, seven novel targeted biologics have launched, with a robust pipeline poised to continue this momentum.
-
3 weeks ago |
spherixglobalinsights.com | Cameron Joseph
Following a period of stability in the US biologic asthma market, new data reveals hidden opportunities for differentiation and growing prescriber interest in emerging pipeline therapies Exton, PA, May 13, 2025 – Although no new biologics for asthma have been approved since the 2021 launch of Tezspire (Amgen/AstraZeneca), recent insights from Spherix Global Insights point to a market primed for innovation.
-
4 weeks ago |
csmonitor.com | Cameron Joseph
President Donald Trump and Salvadoran President Nayib Bukele were all smiles. The leader of the free world and the Central American leader who has described himself as the “world’s coolest dictator” sat in the Oval Office in mid-April, discussing their agreement to send hundreds of deported migrants to El Salvador’s notorious prison system.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 26K
- Tweets
- 34K
- DMs Open
- Yes

With Stephen Miller suggesting Trump might suspend habeas corpus and ICE arresting Newark Mayor Ras Baraka, reupping my magazine cover story that was published yesterday morning: https://t.co/bTaFFW6o9j

When Donna Brazile was just a bit older than Hogg 35 years ago she worked for Eleanor Holmes Norton... who is still in office.

David Hogg: "There've been a few members that have come out, that have said, 'if I retire my life is effectively over'... Get over yourself. This isn't about you." Donna Brazile: "I'm glad David is throwing a rock inside the party... I know what I did when I was his age, I https://t.co/HJLnUlM7Vp

RT @Bencjacobs: ‘If You Can Survive the Hill, You Can Survive in Prison’ https://t.co/ozZ5pa6qSy via @politico